Mendel's neuro-symbolic AI beat GPT-4 at retrieving trial-eligible patient cohorts from 1,400 patient records.
Existing systems struggle to accurately identify eligible patients for trials from electronic medical records. Mendel couples language models with a proprietary hypergraph reasoning engine. In the ACR cohort retrieval benchmark with Cornell it outperformed GPT-4 across 1,400 patient records.
Mendel is a clinical AI company whose neuro-symbolic system reads medical records, used for patient cohort matching and trial eligibility
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Mendel on its own site — read the original case study on clinicaltrialsarena.com ↗
Note: News report on a benchmark rather than a customer deployment.
Related use cases
- 01Novo Nordisk Transforms Clinical Trials With AI
- 02How Regeneron is discovering new treatments with AI
- 03How AI is changing drug discovery
- 04Bayer transforms global data management with Databricks
- 05Delivering timely insights that drive better patient care
- 06Optimizing healthcare revenue cycle management